Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with itMarket Watch • 09/24/25
uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And BeyondSeeking Alpha • 09/24/25
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive FundingGlobeNewsWire • 09/24/25
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's DiseaseGlobeNewsWire • 09/24/25
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry DiseaseGlobeNewsWire • 09/05/25
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a BetZacks Investment Research • 07/31/25
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?Benzinga • 07/30/25
uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company ProgressGlobeNewsWire • 07/29/25
uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy OfficerGlobeNewsWire • 06/11/25
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board ChairGlobeNewsWire • 05/19/25
Wall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?Zacks Investment Research • 05/14/25